Vitamin B6 Pyridoxine Market Overview
- The vitamin B6 (pyridoxine) market size is projected to grow at USD 140.2 million by 2035.
- The target market was valued at USD 91.8 million in 2024.
- Target market is expanding at a CAGR of 4.8%.
Vitamin B6, also known as pyridoxine, is a water-soluble vitamin that human body needs for several functions. Target market is driven by health and wellness trend paired with increasing healthcare costs, increasing demand for animal nutrition. In addition, emerging pharmaceutical and healthcare application, widespread usage in various industries, rising awareness regarding vitamins and supplements are another factors propelling growth of the global market.
Key Takeaways:
- North America held the largest share of the market in 2024 due to widespread awareness regarding vitamins & supplements in the region.
- Asia Pacific is projected to be the fastest-growing market in the coming years. This is due to the rapid urbanization and growing interest on preventive healthcare.
Vitamin B6 Pyridoxine Market Drivers & Restraints
Key Drivers of Target Market:
Emerging Pharmaceutical and Healthcare Applications of Vitamin B6 can Drive Market Expansion
The pharmaceutical industry has increased the consumption of Vitamin B6 to address numerous health problems involving anemia, PMS, and neurological disorders, thus making it a market driver. The extensive involvement of Vitamin B6 in metabolic processes, synthesis of proteins, and neurotransmitter synthesis indicates its crucial use in the treatment of medical conditions, thus raising the level of demand in the healthcare sector.
- For instance, in May 2022, dsm-firmenich has announced that its China Drug Master File (CDMF) for pyridoxine hydrochloride (vitamin B6) has been granted active status. The CDMF plays a critical role in facilitating and accelerating the approval of drug products. With this news, dsm-firmenich is now able to provide full regulatory support to customers developing pharmaceuticals for the Chinese market.
Growing Animal Feed Industry can Propel Growth of Target Market
Vitamin B6 is essential in animal and pet health for growth and metabolism; thus, it makes its way into feed. The rise in demand for high-quality animal products, such as meat, dairy, and eggs, globally with the demand for nutritionally optimized feeds has led to an increase in demand in the Vitamin B6 market in this space.
- For instance, according to the European Food Safety Authority, Pyridoxine hydrochloride or Vitamin B6 is considered to be safe for all animal species at the commercial use levels. The FEEDAP Panel concludes that the use of pyridoxine hydrochloride as a nutritional additive does not give rise to concern for consumers.
Restraints:
High Doses and Potential Side Effects of Vitamin B6 can Hamper Market Growth
Concomitant high intakes of Vitamin B6, especially through supplementation, may cause adverse side effects such as nerve damage, sensory neuropathy, and others, further hampering the vitamin B6 (pyridoxine) market growth. Warnings against over-dosing may offset the positives from the high market growth by questioning the safety aspect with consumers.
- For instance, in June 2023, according to the data published by National Institutes of Health, chronic administration of 1–6 g oral pyridoxine per day for 12 to 40 months can cause severe and progressive sensory neuropathy characterized by ataxia (loss of control of bodily movements). Other effects of excessive vitamin B6 intakes include painful, disfiguring dermatological lesions, photosensitivity, and gastrointestinal symptoms, such as nausea and heartburn.
- Counterbalance Statements: Solutions for high dose and side effects of vitamin B6 are reducing the dose, discontinuing the use, visit a healthcare professional, consumption of vitamin B6 with food, follow the recommended dosage, and others.
Opportunities & Market Trends:
Growth in Personalized Nutrition and Dietary Supplements will Propel Market Growth in Upcoming Years
The trend toward personalized nutrition creates opportunities for Vitamin B6 producers to create tailored products that meet individual health requirements. As the range of genetic testing and customized health assessment spreads, supplementation with Vitamin B6 can become part of a customized health, and wellness package.
For instance, in June 2024, the board of directors of ClouDr Group Limited announced that the application for market launch of Vitamin B6 injection solution developed by Polifarma (Nanjing) Pharmaceutical Company Limited. The Vitamin B6 Injection Solution subject to the application by Nanjing Polifarma is the first batch of Vitamin B6 product subject to consensus evaluation in China, which reflects the stringent control over raw materials of Nanjing Polifarma and the level of advancement of its production process.
Vitamin B6 Pyridoxine Market Segmentations & Regional Insights
The market is segmented into drug type, grade type, application, distribution channel, and region.
Drug Type
On the basis of type, the vitamin B6 (pyridoxine) market is segmented into tablets & capsules, gummies, syrups, and others. The tablets & capsules segment dominate the target market growth with 46.8% of total share due to its chemical stability, widespread availability, and others.
- For instance, in December 2023, Akums Drugs & Pharmaceuticals Ltd announced the launch of Doxylamine + Pyridoxine Hydrochloride (Vitamin B6) extended-release tablets, a therapy approved by the Central Drugs Standard Control Organization (CSDCO), Indian & the U.S. Food & Drug Administration.
Grade Type
The vitamin B6 (pyridoxine) market by grade type is segmented into food grade, feed grade, and pharmaceutical grade. The pharmaceutical grade segment holds the largest share of the market due to increasing demand and usage.
Application
On the basis of application, the vitamin B6 (pyridoxine) market is segmented into Anemia, Dermatitis, Fatigue, Insomnia, Muscle Cramps, Menopausal Depression, Premenstrual Syndrome, Morning Sickness, and others. The Anemia segment is expected to dominate the target market growth due to the widespread usage to treat patients, and among others.
- For instance, according to the article published by University of Rochester Medical Center, Low levels of pyridoxine can cause anemia and many other health problems. Pyridoxine used to treat Metabolic and or genetic problems, such as pyridoxine-dependent convulsions and pyridoxine-responsive anemia.
Distribution Channel
On the basis of distribution channel, the market is segmented into pharmacies & drug stores, supermarkets, online channels, and others. The pharmacies & drug stores segment holds the dominant vitamin B6 (pyridoxine) market share of 51.2% due to its widespread availability, varieties, and others.
Regional
Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America: North America is expected to dominate the growth of the market during forecast period due to the increasing geriatric population, rising awareness about healthy eating habits & supplementation, presence of major players in the region, and others.
- For instance, most children, adolescents, and adults in the United States consume the recommended amounts of vitamin B6, according to an analysis of data of National Health and Nutrition Examination Survey (NHANES). The average vitamin B6 intake is about 1.5 mg/day in women and 2 mg/day in men.
Asia Pacific: Asia Pacific is considered to be the fastest growing region in the target market as countries, such as India, China, and many more are leading the charge significantly due to region’s rapid urbanization, growing interest in preventive healthcare, increasing consumer awareness of health & wellness, large number of dietary supplement consumption, rising regulatory support, and others.
Vitamin B6 (Pyridoxine) Market Report Scope:
Attribute |
Details |
Market Size 2025 |
USD 96.3 Million |
Projected Market Size 2035 |
USD 140.2 Million |
CAGR Growth Rate |
4.8% (2025-2035) |
Base year for estimation |
2024 |
Forecast period |
2025 – 2035 |
Market representation |
Revenue in USD Million & CAGR from 2024 to 2034 |
Regional scope |
North America - U.S. and Canada Europe – Germany, U.K., France, Russia, Italy, Spain, Netherland, and Rest of Europe Asia Pacific – China, India, Japan, Australia, Indonesia Malaysia, South Korea, and Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, and Rest of Latin America Middle East & Africa – GCC, Israel South Africa, and Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segmentation:
By Drug Type:
- Tablets & Capsules
- Gummies
- Syrups
- Others
By Grade Type:
- Food Grade
- Feed Grade
- Pharmaceutical Grade
By Application:
- Anemia
- Dermatitis
- Fatigue
- Insomnia
- Muscle Cramps
- Menopausal Depression
- Premenstrual Syndrome
- Morning Sickness
- Others
By Distribution Channel:
- Pharmacies & Drug Stores
- Supermarkets
- Online Channels
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Vitamin B6 Pyridoxine Market Competitive Landscape & Key Players
The key players operating in the Vitamin B6 (pyridoxine) market include GLOBAL VITAMIN CO., LTD, DSM-FIRMENICH, Chemball.com., Prinova Group LLC, Nanjing pharmaceutical factory Co,ltd., and among Others. These key players focusing on different organic and inorganic strategies such as acquisition, merger, partnership, agreement, product launch and approval to expand their product portfolio, and strengthen their market presence globally.
List of Key Players in the Market:
- GLOBAL VITAMIN CO., LTD
- DSM-FIRMENICH
- Chemball.com.
- Prinova Group LLC
- Nanjing pharmaceutical factory Co,ltd.
- Inga Laboratories P. Ltd.
- TORRENT PHARMACEUTICALS LTD.
- JIANGXI TIANXIN PHARMACEUTICAL CO., LTD
- Rochem International Inc.
- Faran Shimi Pharmaceutical Co.
- Pure Nutrition
- BASIC NUTRITION
- Anhui Techchem Industrial Co., Ltd.
- HEALTHYHEY NUTRITION
- Honor Pharma
Vitamin B6 Pyridoxine Market Recent News
- In November 2024, researchers at the Monash University Biomedicine Discovery Institute have identified a form of Vitamin B6 bound to MR1 as a means of engaging tumour-reactive immune cells. Central to this study were the unbiased mass spectrometry analysis of small molecules bound to MR1, the structural resolution of the interactions between MR1 and Vitamin B6.
- In August 2024, Vitamin B6 and Cognitive Health, a study in the August 2024 edition of Frontiers in Nutrition, sheds light on Vitamin B6 and its function regarding cognitive processes, mainly mood regulation and mental health. Thus, supplement producers have started to tout stress-free and anxiety-reduced psychological well-being resulting from Vitamin B6 supplementation as part of their marketing efforts by introducing product lines focusing on these aspects.
- In June 2024, a research team from Würzburg University Medicine has now discovered another way to increase vitamin B6 levels in cells more effectively namely by specifically inhibiting its intracellular degradation. They identified a natural substance that can inhibit pyridoxal phosphatase and thus slow down the degradation of vitamin B6.
Analyst View:
The industry for vitamin B6 (pyridoxine) market is placed for substantial growth due to health and wellness trend paired with increasing healthcare costs, increasing demand for animal nutrition, emerging pharmaceutical and healthcare application, widespread usage in various industries, rising awareness regarding vitamins and supplements. New innovations and development, advance technologies, and many collaborations and partnerships help to boost the growth of the market in upcoming years.
More Related Reports
Vitamins Market
Vitamin D Market
United States Vitamin D Supplements Market
Preventive Asthma Drugs Market
Implantable Drug Device Market
Vitamin B6 Pyridoxine Market Company Profile
Company Name |
DSM-FIRMENICH |
Headquarter |
Kaiseraugst, Switzerland |
CEO |
Dimitri de Vreeze |
Employee Count (2024) |
30,000 Employees |
Vitamin B6 Pyridoxine Market Highlights
FAQs
The vitamin B6 (pyridoxine) market size was valued at USD 96.3 million in 2025 and is expected to reach USD 140.2 million by 2035 growing at a CAGR of 4.8%.
The market is segmented into drug type, grade type, application, distribution channel, and region.
The market is segmented by region North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. North America is expected to dominate the market.
The key players operating in the Vitamin B6 (pyridoxine) market include GLOBAL VITAMIN CO., LTD, DSM-FIRMENICH, Chemball.com, Prinova Group LLC, Nanjing pharmaceutical factory Co,ltd., Inga Laboratories P. Ltd., TORRENT PHARMACEUTICALS LTD., JIANGXI TIANXIN PHARMACEUTICAL CO., LTD., Rochem International Inc., Faran Shimi Pharmaceutical Co., Pure Nutrition, BASIC NUTRITION, Anhui Techchem Industrial Co.,Ltd., and HEALTHYHEY NUTRITION., and Honor Pharma